FDA Approves AnaptysBio-Discovered Drug for Rectal Cancer
The FDA granted accelerated approval to Jempezi, a drug discovered by AnaptysBio. Shares gained 5.8% to $49.31 in Monday afternoon trading.
AnaptysBio shares advanced after the Food and Drug Administration approved Jempe… for treating rectal cancer. The drug was discovered by AnaptysBio. The stock climbed 5.8% to $49.31 in Monday afternoon trading and is up 53% this year. The FDA granted accelerated approval to Jempe…